Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Dementia is one of the most common and important aspects of Parkinson's disease and has
consequences for patients and caregivers, and has health-related costs. Mild cognitive …
consequences for patients and caregivers, and has health-related costs. Mild cognitive …
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
The NINCDS–ADRDA and the DSM-IV-TR criteria for Alzheimer's disease (AD) are the
prevailing diagnostic standards in research; however, they have now fallen behind the …
prevailing diagnostic standards in research; however, they have now fallen behind the …
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and
pathologic diagnosis of DLB incorporating new information about the core clinical features …
pathologic diagnosis of DLB incorporating new information about the core clinical features …
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Dementia has been increasingly more recognized to be a common feature in patients with
Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of …
Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of …
Neuroimaging advances in Parkinson's disease and atypical Parkinsonian syndromes
Parkinson's disease (PD) and atypical Parkinsonian syndromes are progressive
heterogeneous neurodegenerative diseases that share clinical characteristic of …
heterogeneous neurodegenerative diseases that share clinical characteristic of …
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts
Two centuries ago in 1817, James Parkinson provided the first medical description of
Parkinson's disease, later refined by Jean-Martin Charcot in the mid-to-late 19th century to …
Parkinson's disease, later refined by Jean-Martin Charcot in the mid-to-late 19th century to …
Dementia with Lewy bodies
Dementia with Lewy bodies (DLB) is the second commonest cause of neurodegenerative
dementia in older people. It is part of the range of clinical presentations that share a neuritic …
dementia in older people. It is part of the range of clinical presentations that share a neuritic …
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
G Waldemar, B Dubois, M Emre… - European Journal of …, 2007 - Wiley Online Library
The aim of this international guideline on dementia was to present a peer‐reviewed
evidence‐based statement for the guidance of practice for clinical neurologists, geriatricians …
evidence‐based statement for the guidance of practice for clinical neurologists, geriatricians …
Molecular tracers for the PET and SPECT imaging of disease
SL Pimlott, A Sutherland - Chemical Society Reviews, 2011 - pubs.rsc.org
The development of positron emission tomography (PET) and single photon emission
computed tomography (SPECT) imaging continues to grow due to the ability of these …
computed tomography (SPECT) imaging continues to grow due to the ability of these …
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study
Summary Background Dementia with Lewy bodies (DLB) needs to be distinguished from
other types of dementia because of important differences in patient management and …
other types of dementia because of important differences in patient management and …